
Dr. Armando Partida-Gaytán,MD, MSc
An internationally trained physician dedicated to allergy, clinical immunology and type 2 inflammatory disease in adults and children. Training across Mexico, the United Kingdom and Latin America informs an evidence-based, precision-medicine approach — from advanced allergy diagnostics to modern biologic therapies — delivered in English or Spanish.
- Evidence-Based Medicine
- International Medical Leadership
- Adult & Pediatric Care
- Precision Allergy & Immunology
- English & Spanish Consultations
Making complex allergic diseases understandable.
Allergy Smart Suite was created out of a simple observation: patients living with severe asthma, chronic urticaria, atopic dermatitis, food allergy or recurrent immune disease often arrive having been seen by several physicians, yet still without a clear explanation of what they have, why it happens, and what to do about it.
Modern allergy and clinical immunology is a precision specialty. Phenotype, endotype and biomarkers should guide decisions — not generic treatment ladders. Patients deserve the time to be heard, diagnostics that actually clarify the picture, and a treatment plan that is explained, not just prescribed.
Education is part of treatment. When patients and families understand their disease, adherence improves, anxiety drops, and outcomes change.
Three principles behind every consultation.
Every recommendation combines current scientific evidence with individualized clinical judgement — never one-size-fits-all.
Patients and families participate in every meaningful treatment decision, with the time and clarity they deserve.
Modern diagnostics and targeted therapies — including biologics — allow treatment tailored to your specific disease biology.
Specialty-level depth, designed around the patient.
Allergy, immunology and respiratory disease assessed as one system, not in isolation.
Candidacy assessment and orientation for biologics in severe asthma, CRSwNP, urticaria and atopic dermatitis.
Component-resolved allergy testing, pulmonary function, immune workup and phenotype-driven evaluation.
Clear, structured explanations so you understand your diagnosis and treatment plan in your own language.
Training and collaboration across Mexico, the UK and Latin America inform every clinical decision.
Chronic allergic and immunologic disease requires continuity — we build that relationship deliberately.
Two decades of training, distilled into how you are cared for today.
- 2002 — 2011
Clinical Foundation
Medical degree at Universidad de Guadalajara, followed by Pediatrics residency at Hospital Infantil de México Federico Gómez — first place academic performance, class of 2008–2011.
A foundation in pediatric and general medicine that informs how complex allergic disease is evaluated at any age.
- 2011 — 2014
Subspecialty in Allergy & Immunology
Fellowships in Paediatric Allergy & Clinical Immunology and a high-specialty fellowship in Primary Immunodeficiencies (UNAM / Instituto Nacional de Pediatría), with an MSc in Medical Sciences.
Deep training in the immune system — from common allergy to rare immunodeficiency — supports accurate diagnosis where others stop.
- 2015 — 2016
International Academic Development
MSc Cell and Gene Therapy at University College London — Great Ormond Street Institute of Child Health. Awarded Distinction and Dean's List.
Exposure to the frontier of advanced therapies shapes a forward-looking view of what is possible in immune disease.
- 2016 — present
Industry & Medical Leadership
Senior Medical Affairs Manager — Specialty Care at GSK México, leading medical strategy across biologics, severe asthma, respiratory immunology and rare disease. Three-time Top Performer of the Year.
Direct insight into how modern biologics are developed, evaluated and accessed — translated into practical orientation for each patient.
- 2024 →
Allergy Smart Suite®
Founding Director of Allergy Smart Suite at Hospital San Ángel Inn Satélite — a focused, digitally enabled practice in allergy, clinical immunology and type 2 inflammatory disease.
A care model designed end-to-end around clarity, precision and long-term partnership.
A broader perspective, applied to your case.
Training at University College London — Great Ormond Street Institute of Child Health, contribution to Latin American consensus documents in severe combined immunodeficiency, and co-authorship of the Mexican GUIMIT immunotherapy guidelines have shaped a view of allergy and immunology that is rigorously international.
That perspective is what allows a treatment plan to draw on European, North American and Latin American evidence simultaneously — choosing what genuinely fits each patient instead of what is locally familiar.
Focused on type 2 inflammatory and severe allergic disease.
Phenotype-driven evaluation and biologic orientation for uncontrolled and eosinophilic asthma.
Integrated management of chronic rhinosinusitis with nasal polyps in coordination with ENT.
Structured workup and stepwise therapy, including biologic options, for chronic spontaneous urticaria.
Moderate-to-severe atopic dermatitis with modern systemic and targeted therapies.
Diagnostic clarification, anaphylaxis risk assessment and long-term management.
Evaluation of suspected drug reactions and orientation around desensitization protocols.
High-specialty training in inborn errors of immunity — recognition, workup and care navigation.
Candidacy, expectations and follow-up for monoclonal antibodies across type 2 inflammatory disease.
Phenotype, endotype and biomarker-driven decisions instead of generic treatment ladders.
A continuous formation in medicine and immunology.
- 2002 — 2008
Medical Degree
Universidad de Guadalajara - 2008 — 2011
Pediatrics Residency
Hospital Infantil de México Federico GómezFirst place academic performance - 2011 — 2013
Fellowship — Paediatric Allergy & Clinical Immunology
Hospital Infantil de México Federico Gómez - 2013 — 2014
High-specialty Fellowship — Primary Immunodeficiencies
UNAM / Instituto Nacional de Pediatría - 2012 — 2014
MSc Medical Sciences
Hospital Infantil de México Federico Gómez - 2015 — 2016
MSc Cell and Gene Therapy
University College London — Great Ormond Street Institute of Child HealthDistinction · Dean's List - 2023 — 2025
Executive Education
ESCP Business School · Universidad Anáhuac · DAIS
Active participation in the evidence that shapes practice.
Peer-reviewed publications, book chapters, regional consensus documents and international meetings — focused on severe asthma, allergen immunotherapy, primary immunodeficiencies, gene therapy and pediatric immunology.
View Full Academic CVJournal of Clinical Investigation · Journal of Allergy and Clinical Immunology · Clinical Immunology · Frontiers in Immunology · World Allergy Organization Journal · Molecular Therapy — Methods & Clinical Development · Bone · Nutrients · European Journal of Clinical Nutrition.
Academic, clinical and leadership distinctions.
MSc Cell and Gene Therapy, University College London.
GSK México — 2017, 2023 and 2024.
First Place — Rio de Janeiro, 2023.
Awardee and Innovation Champion across Mexico, LATAM and Emerging Markets.
Pediatrics (CMCP) and Clinical Immunology & Allergy (CONICA) — current.
First place academic performance — Pediatrics Residency, HIMFG.
“Medicine should reduce uncertainty — not create more of it.”
Every consultation is built to replace confusion with understanding, and fragmented care with an integrated, evidence-based plan. The goal is not to add another opinion — it is to bring the pieces together so that you finally know what you have, why it happens, and what to do next.
Six reasons to expect more from your specialty care.
Recommendations grounded in current international guidelines and primary literature.
Time to listen, examine and review prior studies in full — not in fifteen minutes.
Component-resolved allergy testing, lung function, immune workup and biomarker review.
Training in Mexico, the UK and across Latin America — applied to your case.
Orientation on biologics and emerging treatments when they are right for your phenotype.
A continuous clinical relationship designed for chronic, evolving disease.
Let's find the answers together.
Whether you are looking for a second opinion, advanced biologic therapy, comprehensive allergy evaluation or international consultation, Allergy Smart Suite was designed to provide clarity, confidence and personalized care.
